Protocol CAUSE-03 / CHEETAH
Part of paid clinical trials in Aurora, Colorado.
- Sponsor
- National Institute of Allergy and Infectious Diseases (NIAID)
- Study ID
- NCT06136091
- Status
- Recruiting
Conditions
Eligibility Criteria
- Sex
- ALL
- Age
- 6 Years - 17 Years
- Healthy Volunteers
- Accepted
Study Details
This is a one-year longitudinal, observational study of 250 urban children and adolescents with asthma and 60 without asthma, ages 6-17 years old. Participants with asthma will require daily controller therapy with inhaled corticosteroids ICS (at least Step 2 therapy). Those without asthma cannot have used asthma medications in the year prior to enrollment and cannot demonstrate bronchodilator reversibility at baseline. Phenotypic characteristics will be established at baseline, and the participants will be seen at scheduled visits over 12 months. Each participant will be asked to monitor and self-report cold symptoms and will be asked to complete up to three cold visits
Key Dates
- Start date
- Apr 23, 2024
- Status verified
- May 2025
- Primary completion
- May 1, 2027
- Completion
- May 1, 2027
Study Design
- Enrollment
- 310 participants (estimated)
Arms
- Arm: Asthma groupParticipants ages 6 to 17 year old in the asthma group will be seen in clinic quarterly for one year, during periods of disease control when they are not on systemic corticosteroids (SCS)
- Arm: Non-asthma groupParticipants in the non-asthma group will be seen at two scheduled visits in clinic at 3 and 12 months and will have telephone visits at 6 and 9 months
Primary Outcome Measure
Asthma disease activity measured by the number of exacerbations during the 12-month observation period [ Time Frame: Month 0 to Month 12 ]
Locations (8)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| Children's Hospital Colorado: Allergy Program | Aurora | Colorado | 80045 | |
| Children's National Medical Center: Children's Research Institute | Washington D.C. | District of Columbia | 20010 | |
| Ann & Robert H. Lurie Children's Hospital of Chicago: Division of Allergy and Immunology | Chicago | Illinois | 60611 | - |
| Boston Children's Hospital: Department of Immunology | Boston | Massachusetts | 02215 | - |
| Boston University School of Medicine: Pulmonary Center | Boston | Massachusetts | 02118 | |
| Columbia University Medical Center: Division of Pediatric Pulmonology | New York | New York | 10032 | - |
| Icahn School of Medicine at Mount Sinai: Division of Clinical Immunology, Immunology Institute | New York | New York | 10029 | - |
| Cincinnati Children's Hospital Medical Center: Asthma Center | Cincinnati | Ohio | 45229 | - |
Find similar trials in Aurora, CO
Related Studies
- Pilot Study to Identify the Mediators and Inflammatory Cell Surface Receptors Involved in Allergic Airway InflammationPHASE1 · Recruiting · Benjamin Medoff · Boston, Massachusetts
- Asthma Inflammation ResearchEARLY_PHASE1 · Enrolling By Invitation · The Cleveland Clinic · Cleveland, Ohio
- Reslizumab in the Treatment of Eosinophilic Granulomatosis With Polyangiitis (EGPA) StudyPHASE2 · Recruiting · National Jewish Health · Denver, Colorado
- Obesity, Metabolic Dysregulation and the Airway Epithelium in AsthmaticsRecruiting · University of Colorado, Denver · Aurora, Colorado